This booklet is for gay and bisexual men who are having tests or treatment for prostate cancer. We’ve included information that may be particularly relevant to you, as well as information about the support available.

Last updated: October 2018
To be reviewed: October 2021

References  

Updated: October 2018 | Due for Review: October 2021

  • Achterbergh RCA, Helm J van der, Boom W van den, Heijman T, Stolte IG, Rooijen M van, et al. Is rectal douching and sharing douching equipment associated with anorectal chlamydia and gonorrhoea? A cross-sectional study among men who have sex with men. Sex Transm Infect. 2017 Sep 1;93(6):431–7.
  • Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. The Lancet [Internet]. 2017 Jan [cited 2017 Jan 20]; Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673616324011
  • Blank TO. Gay Men and Prostate Cancer: Invisible Diversity. J Clin Oncol. 2004 Sep 27;23(12):2593–6.
  • Bower M, Palfreeman A, Alfa-Wali M, Bunker C, Burns F, Churchill D, et al. British HIV Association guidelines for HIV-associated malignancies 2014. HIV Med. 2014 Mar;15:1–92.
  • Cancer Research UK. Cancer incidence for common cancers (2015) [Internet]. [cited 2016 May 19]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/common-cancers-compared
  • Cancer Research UK. Prostate cancer incidence statistics: by age (2013-2015) [Internet]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence#heading-One
  • Cancer Research UK. Prostate cancer incidence statistics: Lifetime risk of prostate cancer (2012) [Internet]. [cited 2016 Jul 6]. Available from: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence#heading-Four
  • Capistrant BD, Torres B, Merengwa E, West WG, Mitteldorf D, Rosser BRS. Caregiving and social support for gay and bisexual men with prostate cancer. Psychooncology. 2016 Nov;25(11):1329–36.
  • Chipperfield K, Brooker J, Fletcher J, Burney S. The impact of physical activity on psychosocial outcomes in men receiving androgen deprivation therapy for prostate cancer: A systematic review. Health Psychol. 2014;33(11):1288–97.
  • Cornell D. A Gay Urologist’s Changing Views on Prostate Cancer. J Gay Lesbian Psychother. 2005 Feb 15;9(1–2):29–41.
  • Department of Health. The NHS Constitution for England. 2015.
  • Dowsett GW. ‘ Losing My Chestnut’: One Gay Man’s Wrangle with Prostate Cancer. Reprod Health Matters. 2008;145–150.
  • Elliott MN, Kanouse DE, Burkhart Q, Abel GA, Lyratzopoulos G, Beckett MK, et al. Sexual Minorities in England Have Poorer Health and Worse Health Care Experiences: A National Survey. J Gen Intern Med. 2015 Jan;30(1):9–16.
  • Equality Act 2010. 
  • Frey AU, Sønksen J, Fode M. Neglected Side Effects After Radical Prostatectomy: A Systematic Review. J Sex Med. 2014 Feb;11(2):374–85.
  • Goldstone SE. The Ups and Downs of Gay Sex After Prostate Cancer Treatment. J Gay Lesbian Psychother. 2005 Feb 15;9(1–2):43–55.
  • Hart TL, Coon DW, Kowalkowski MA, Zhang K, Hersom JI, Goltz HH, et al. Changes in Sexual Roles and Quality of Life for Gay Men after Prostate Cancer: Challenges for Sexual Health Providers: Gay Men with Prostate Cancer and HRQOL. J Sex Med. 2014 Sep;11(9):2308–17.
  • Hatzimouratidis K, Giuliano F, Moncada I, Muneer A, Salonia A, Verze P. EAU guidelines on erectile dysfunction, premature ejaculation, penile curvature and priapism. European Association of Urology; 2016.
  • Hoyt MA, Frost DM, Cohn E, Millar BM, Diefenbach MA, Revenson TA. Gay men’s experiences with prostate cancer: Implications for future research. J Health Psychol. 2017 Jun 15;1359105317711491.
  • Hulbert-Williams NJ, Plumpton C o., Flowers P, McHugh R, Neal R d., Semlyen J, et al. The cancer care experiences of gay, lesbian and bisexual patients: A secondary analysis of data from the UK Cancer Patient Experience Survey. Eur J Cancer Care (Engl). 2017 Jul 1;26(4):n/a-n/a.
  • Izadmehr S, Leapman M, Hobbs AR, Katsigeorgis M, Nabizada-Pace F, Jazayeri SB, et al. Clinical characteristics and outcomes of HIV-seropositive men treated with surgery for prostate cancer. Int Urol Nephrol. 2016 Oct;48(10):1639–45.
  • Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int. 2003;91(9):789–794.
  • Kelly D, Sakellariou D, Fry S, Vougioukalou S. Heteronormativity and prostate cancer: a discursive paper. J Clin Nurs [Internet]. 2017 Apr 5 [cited 2017 May 2]; Available from: http://doi.wiley.com/10.1111/jocn.13844
  • Kiciński M, Vangronsveld J, Nawrot TS. An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis. PLoS ONE. 2011 Oct 31;6(10):e27130.
  • Kimura M, Caso JR, Bañez LL, Koontz BF, Gerber L, Senocak C, et al. Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy. BJU Int. 2012 Dec;110(11 Pt C):E931-938.
  • Kirby MG, White ID, Butcher J, Challacombe B, Coe J, Grover L, et al. Development of UK recommendations on treatment for post-surgical erectile dysfunction. Int J Clin Pract. 2014 May;68(5):590–608.
  • Klein LT, Lowe FC. The effects of prostatic manipulation on prostate-specific antigen levels. Urol Clin North Am. 1997 May;24(2):293–7.
  • Latini DM, Hart SL, Coon DW, Knight SJ. Sexual rehabilitation after localized prostate cancer: current interventions and future directions. Cancer J Sudbury Mass. 2009 Feb;15(1):34–40.
  • Lee TK, Handy AB, Kwan W, Oliffe JL, Brotto LA, Wassersug RJ, et al. Impact of Prostate Cancer Treatment on the Sexual Quality of Life for MenWhoHaveSexwithMen. J Sex Med. 2015 Dec;12(12):2378–86.
  • Lisy K, Peters MDJ, Schofield P, Jefford M. Experiences and unmet needs of lesbian, gay and bisexual people with cancer care: a systematic review and meta-synthesis. Psychooncology. 2018;n/a-n/a.
  • Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010. BMC Med [Internet]. 2015 Dec [cited 2015 Nov 5];13(1). Available from: http://www.biomedcentral.com/1741-7015/13/171
  • Matheson L, Watson E k., Nayoan J, Wagland R, Glaser A, Gavin A, et al. A qualitative metasynthesis exploring the impact of prostate cancer and its management on younger, unpartnered and gay men. Eur J Cancer Care (Engl). 2017 Nov 1;26(6):n/a-n/a.
  • Michaelson MD, Cotter SE, Gargollo PC, Zietman AL, Dahl DM, Smith MR. Management of Complications of Prostate Cancer Treatment. CA Cancer J Clin. 2008 Mar 19;58(4):196–213.
  • Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. In: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2012 [cited 2015 Sep 22]. Available from: http://doi.wiley.com/10.1002/14651858.CD008465.pub2
  • Muirhead GJ, Wulff MB, Fielding A, Kleinermans D, Buss N. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir. Br J Clin Pharmacol. 2000 Aug;50(2):99–107.
  • Nasser NJ, Cohen GN, Dauer LT, Zelefsky MJ. Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy. Brachytherapy. 2016 Aug;15(4):420–5.
  • National Institute for Health and Care Excellence. Lower urinary tract symptoms in men: assessment and management. NICE Clinical Guideline 97 [Internet]. (modified June 2015); 2010. Available from: https://www.nice.org.uk/guidance/cg97
  • National Institute for Health and Care Excellence. Prostate Cancer: diagnosis and treatment. Full guideline 175. 2014.
  • National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NICE Guideline 12. June 2015 [Internet]. 2015. Available from: http://www.nice.org.uk/guidance/ng12/evidence/full-guidance-65700685
  • NHS England. Sexual Orientation Monitoring Information Standard [Internet]. 2017 [cited 2018 Jun 29]. Available from: https://www.england.nhs.uk/about/equality/equality-hub/sexual-orientation-monitoring-information-standard/
  • Olsson CE, Alsadius D, Pettersson N, Tucker SL, Wilderäng U, Johansson K-A, et al. Patient-reported sexual toxicity after radiation therapy in long-term prostate cancer survivors. Br J Cancer. 2015 Sep 1;113(5):802–8.
  • Pillet S. Don’t ask, don’t tell? The unique needs of GLBT patients with cancer. Connect. 2011 Jan;26(1):8–12.
  • Prostate Cancer UK and Stonewall. Exploring the needs of gay and bisexual men dealing with prostate cancer. 2013.
  • Public Health England. Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing [Internet]. GOV.UK; 2016. Available from: https://www.gov.uk/government/publications/prostate-cancer-risk-management-programme-psa-test-benefits-and-risks/prostate-cancer-risk-management-programme-pcrmp-benefits-and-risks-of-psa-testing
  • Ralph S, Richardson C. Developing UK guidance on how long men should abstain from receiving anal sex before, during, and after investigations and treatments for prostate cancer [MClin Res dissertation]. University of Manchester; 2018.
  • Rosario DJ, Lane JA, Metcalfe C, Donovan JL, Doble A, Goodwin L, et al. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ. 2012;344:d7894.
  • Rose D, Ussher JM, Perz J. Let’s talk about gay sex: gay and bisexual men’s sexual communication with healthcare professionals after prostate cancer. Eur J Cancer Care (Engl). 2017 Jan;26(1):e12469.
  • Rosenblatt KA, Wicklund KG, Stanford JL. Sexual factors and the risk of prostate cancer. Am J Epidemiol. 2001 Jun 15;153(12):1152–8.
  • Rosser BRS, Capistrant B, Torres MB, Konety B, Merengwa E, Mitteldorf D, et al. The effects of radical prostatectomy on gay and bisexual men’s sexual functioning and behavior: qualitative results from the restore study. Sex Relatsh Ther. 2016 Oct 1;31(4):432–45.
  • Rosser BRS, Merengwa E, Capistrant BD, Iantaffi A, Kilian G, Kohli N, et al. Prostate cancer in gay, bisexual, and other men who have sex with men: A review. LGBT Health. 2016;3(1):32–41.
  • Saunders CL, Meads C, Abel GA, Lyratzopoulos G. Associations Between Sexual Orientation and Overall and Site-Specific Diagnosis of Cancer: Evidence From Two National Patient Surveys in England. J Clin Oncol. 2017 Nov 10;35(32):3654–61.
  • Spence AR, Rousseau M-C, Parent M-É. Sexual partners, sexually transmitted infections, and prostate cancer risk. Cancer Epidemiol. 2014 Dec 1;38(6):700–7.
  • Sullivan JF, Stember DS, Deveci S, AkinOlugbade Y, Mulhall JP. Ejaculation Profiles of Men Following Radiation Therapy for Prostate Cancer. J Sex Med. 2013 May;10(5):1410–6.
  • Tarhan F, Orçun A, Küçükercan I, Camursoy N, Kuyumcuoğlu U. Effect of prostatic massage on serum complexed prostate-specific antigen levels. Urology. 2005 Dec;66(6):1234–8.
  • Terrence Higgins Trust. Interactions with other drugs [Internet]. 2017 [cited 2018 Jun 27]. Available from: https://www.tht.org.uk/hiv-and-sexual-health/living-well-hiv/hiv-treatment/interactions-other-drugs
  • Thomas C, Wootten A, Robinson P. The experiences of gay and bisexual men diagnosed with prostate cancer: results from an online focus group: Gay and bisexual men diagnosed with prostate cancer. Eur J Cancer Care (Engl). 2013 Jul;22(4):522–9.
  • Tran S, Boissier R, Perrin J, Karsenty G, Lechevallier E. Review of the Different Treatments and Management for Prostate Cancer and Fertility. Urology. 2015 Nov;86(5):936–41.
  • Ussher JM, Perz J, Kellett A, Chambers S, Latini D, Davis ID, et al. Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men With Heterosexual Men. J Sex Med. 2016 Mar;13(3):425–34.
  • Ussher JM, Perz J, Rose D, Dowsett GW, Chambers S, Williams S, et al. Threat of Sexual Disqualification: The Consequences of Erectile Dysfunction and Other Sexual Changes for Gay and Bisexual Men With Prostate Cancer. Arch Sex Behav. 2017 Oct 1;46(7):2043–57.
  • Ussher JM, Rose D, Perz J. Mastery, isolation, or acceptance: Gay and bisexual men’s construction of aging in the context of sexual embodiment after prostate cancer. J Sex Res. 2017 Jul;54(6):802–12.
  • Wassersug RJ, Lyons A, Duncan D, Dowsett GW, Pitts M. Diagnostic and Outcome Differences Between Heterosexual and Nonheterosexual Men Treated for Prostate Cancer. Urology. 2013 Jun 14;
  • White ID, Wilson J, Aslet P, Baxter AB, Birtle A, Challacombe B, et al. Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer. Int J Clin Pract. 2015 Jan;69(1):106–23.
  • World Cancer Research Fund International. Continuous Update Project report: Diet, Nutrition, Physical Activity and Prostate Cancer [Internet]. 2014. Available from: www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf
  • Wosnitzer MS, Lowe FC. Management of prostate cancer in HIV-positive patients. Nat Rev Urol. 2010 Jun;7(6):348–57.

Order printed copies of this publication

Before you order we would like to know who you are, and why you are ordering printed copies.

Download digital versions of this publication